Laser technician Denise Sediq prepares the right eye of Lt. Colonel Thomas Hite, Jr. for corrective eye surgery at Walter Reed Army Medical Center June 11, 2002 in Washington, DC. (Photo by Stefan Zaklin/Getty Images)
The federal agency has issued a 25-page draft report outlining how doctors should better inform patients about the potential for double vision, dry eyes, poor night vision, eye pain and other side effects after LASIK surgery.
“This concept that cells ‘fight back’ against modified RNA is of practical importance, as it suggests how one might improve the effectiveness of RNA therapy.”
Researchers from the Smidt Heart Institute have unveiled a novel concept — they harnessed modified messenger RNA (mRNA) technology used in creating the Pfizer and Moderna Covid-19 vaccines, which can be a significant step in the evolution and creation of biological pacemakers.
Luismmolina/iStock.
The investigators identified how biological pacemaker cells could “fight back” against therapies to biologically correct abnormal heartbeat rates. They’ve also found a new way to “boost the effectiveness” of RNA therapies by controlling the “fighting back” activity, they said in a release.
Circulating tumor cells are tumor cells found circulating in the blood that come from a primary tumor. Circulating tumor cells have utility in clinical applications, including genomic analysis of cancer cells and monitoring the progression or recurrence of cancer. Since circulating tumor cells are usually collected through a blood sample, this method is relatively noninvasive compared with traditional tissue biopsies.
Research presented at the San Antonio Breast Cancer Symposium (held December 6–10, 2022) suggests that a count of circulating tumor cells could help clinicians decide between chemotherapy and endocrine therapy as first-line treatment for certain types of breast cancer.
Using circulating tumor cell (CTC) count to decide between first-line treatments provided an overall survival benefit for patients with metastatic, estrogen receptor (ER)-positive/HER2-negative breast cancer when compared to the physician’s choice of treatment.
Artificial intelligence, interpreting data from a device placed at the brain’s surface, enables people who are paralyzed or have severely impaired limb movement to communicate by text.
We celebrate the Remembrance of the Resurrectables each year. A ceremony for remembering all of the patients that are in Cryonic Suspension awaiting an eventual return to a full healthy life.
Go To https://youtu.be/NgdwYAWCy88 for part 1 of our service: Dr. Richard Olree “Minerals for Telomeres” and “Age Reversal Update” with Bill Faloon.
“Our task is to make nature, the blind force of nature, into an instrument of universal resuscitation and to become a union of immortal beings.“
- Nikolai F. Fedorov.
We hold faith in the technologies & discoveries of humanity to END AGING and Defeat involuntary Death within our lifetime.
Working to Save Lives with Age Reversal Education.
Have you ever heard of the yeast Candida auris? If not, you are most likely not the only one since it hasn’t garnered much attention. Yet. That could change.
Candida auris’s story begins in 2009 when a Japanese woman in her 70s is admitted to the Tokyo Metropolitan Geriatric Hospital. Her ear sometimes discharges something, and the doctors routinely use a cotton swab to collect samples of it. To determine what is causing the infection, they analyze the sample.
It turns out that a yeast, different from other known yeasts, is at play. We’ve all heard of baker’s yeast, a friendly microorganism used to make beer and bread. Candida auris and other Candida yeast species are extremely different; they cause serious and persistent infections that are difficult to treat with known antibiotics.
WebMD’s Chief Medical Officer, John Whyte, MD, speaks with Alicja Rudnicka, Professor, Statistical Epidemiology, St. George’s University of London, about an artificial intelligence-enhanced retinal exam that could help predict your risk for cardiovascular disease.
PROVIDENCE, R.I. [Brown University] — When it comes to predicting disasters brought on by extreme events (think earthquakes, pandemics or “rogue waves” that could destroy coastal structures), computational modeling faces an almost insurmountable challenge: Statistically speaking, these events are so rare that there’s just not enough data on them to use predictive models to accurately forecast when they’ll happen next.
But a team of researchers from Brown University and Massachusetts Institute of Technology say it doesn’t have to be that way.
In a new study in Nature Computational Science, the scientists describe how they combined statistical algorithms — which need less data to make accurate, efficient predictions — with a powerful machine learning technique developed at Brown and trained it to predict scenarios, probabilities and sometimes even the timeline of rare events despite the lack of historical record on them.
BERLIN — A biotechnologist in Germany is developing the world’s first artificial womb facility, and it lets you choose baby’s characteristics from a menu. EctoLife, able to grow 30,000 babies a year, is said to be based on over fifty years of groundbreaking scientific research.
The concept is the brainchild of Berlin-based Hashem Al-Ghaili. He says the facilities would allow infertile couples to conceive a baby and become the true biological parents of their own offspring.
A so-called ‘Elite Package’ would allow you to genetically engineer the embryo before implanting it into the artificial womb. Everything from eye and hair color to strength, height, and intelligence can be chosen, and inherited genetic diseases can be avoided.
Many medical treatments have toxicities, sometimes called adverse events, which can complicate a patient’s treatment regimen. Treatment-related adverse events can range from mild symptoms, like transient fatigue or nausea, to severe and lethal occurrences, including cardiac toxicity.
Cardiac toxicity, which manifests as indications like acute myocardial infarction (MI), and angina pectoris (AP), can occur in cancer survivors, even several years following successful treatment. The onset of heart-related adverse events long after treatment is known as late cardiac toxicity, which can become a lethal complication of cancer therapies like radiation and chemotherapy.
The mechanism underlying late cardiac toxicity remains poorly understood. Further, limited interventions to prevent or minimize these symptoms exist. This creates an urgent need to study this relationship and develop therapeutics which can stop or prevent late cardiac toxicity in cancer survivors.
